LCTX – lineage cell therapeutics, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LCTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/6

08:00 am

lctx

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

Neutral Report

Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience

Report

1/5

08:00 am

lctx

Lineage Cell Therapeutics Issues Letter to Stockholders

Low Report

Lineage Cell Therapeutics Issues Letter to Stockholders

Report

12/16

11:53 am

lctx

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

Low Report

Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy

Report

11/13

04:12 am

lctx

Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy [Seeking Alpha]

Medium Report

Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy [Seeking Alpha]

Report

11/12

08:55 am

lctx

Dimension Bio Announces Inaugural Clinical and Scientific Advisory Boards

Medium Report

Dimension Bio Announces Inaugural Clinical and Scientific Advisory Boards

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.